Navigation Links
Herborium Group Shareholders Update
Date:10/27/2011

commercialized or is ready for commercialization. Herborium has also secured a pipeline of product extensions that will assure the Company's positioning  in the marketplace and stream of revenues. The combined market for non-traditional treatments and healthy lifestyles expenditures in the USA alone exceeds $50 Billion with natural medicine being responsible for over 70% of the spending.  The overall potential for botanical drugs may exceed $3 trillion USD worldwide.

Herborium lead Botanical Therapeutic® - AcnEase® , (www.acnease.com is all botanical ingredients based medicine that addresses the need for an effective and safe solution  in the treatment of acne and symptoms of Rosacea.. The National Institute of Arthritis and Musculoskeletal and Skin Diseases Website (Division of National Institutes of Health) reports that in the US alone nearly 85% of people between the ages of 12 and 24 develop acne, and 60 million Americans have existing acne. Rosacea afflicts over 17 million Americans and is a much more prevailing problem in Europe with no known solution in sight.  AcnEase is an all natural systemic product that safely and effectively targets acne and Rosacea in both females and males of all ages.  The results of AcnEase have been impressive with up to 95% of patients seeing improvement after the first course of treatment. Those suffering from symptoms of Rosacea noted up to 90% improvement in skin related symptoms as well as GI and opthomological symptoms.

During the recent months, a significant progress has been made through our marketing efforts, with special focus on Social Marketing strategy, to capitalize on the unique benefits of AcnEase, and on growing consumer needs, exasperated by a recent withdrawal of the Roche Pharmaceutical product - Accutane , the only systemic competition for AcnEas, and by the increasing demand for natural medicines.

Those and other
'/>"/>

SOURCE Herborium Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
2. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
3. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
4. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
5. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
6. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
7. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
8. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
9. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
10. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
11. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Conkwest, Inc., ... developing the proprietary Natural Killer (NK) cell-line platform, ... Dr. Patrick Soon-Shiong , NantWorks founder, physician ... definitive agreement to purchase approximately $48 million of ... with the investment, he will be named Co-Chairman ...
(Date:12/24/2014)... PHILADELPHIA , Dec. 23, 2014 ... a medical device company focused on skin permeation, ... that Scott W. Hollander has been ... Mr. Hollander has more than 20 years of ... equipment industries, and most recently served as Vice ...
(Date:12/24/2014)... Ohio , Dec. 23, 2014   ... treatment decision support to healthcare providers for behavioral ... it has secured $30 million in equity financing ... Virginia C. Drosos , President and Chief Executive ... clinical adoption and development of Assurex Health,s ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4
... Medical Simulation Corporation (MSC) proudly announces a new agreement ... Medical School and a healthcare leader in patient quality, ... system, Simantha ®, and MSC,s curriculum and training ... and patient safety goals over the next three years. ...
... Pfizer (NYSE: PFE ) today ... Inc., a privately held drug discovery and clinical development ... a wholly owned subsidiary of Pfizer Inc.   ... Pfizer Inc: Working together for a healthier ...
Cached Medicine Technology:Medical Simulation Corporation Signs Agreement With a Nationally Ranked Hospital 2
(Date:12/26/2014)... 26, 2014 Plugin and template developers from ... 5 Plugin for Final Cut Pro X. , “TransPack Volume ... tool to pull off an industry professional look” Said Christina ... hands on TransPack Volume 5, a new level of professionalism ... set of over 50 Final Cut Pro X transitions featuring ...
(Date:12/26/2014)... December 26, 2014 Pentec Health, Inc. ... the state of Pennsylvania for 2014. The awards program, ... programs of its kind in the country. The program ... Pennsylvania Department of Community and Economic Development, the Pennsylvania ... and the Central Penn Business Journal. , ...
(Date:12/25/2014)... The microscopy market is estimated to grow ... million by 2019. Optical microscopy is the largest ... product segment is expected to show the fastest ... on nanotechnology, technological advancements, and increasing federal support ... Get Full Copy of Report @ http://www.marketsandmarkets.com/Market-Reports/world-microscopy-399.html ...
(Date:12/25/2014)... Dallas, TX (PRWEB) December 26, 2014 ... and Market Analysis to 2023” focuses on the ... commercial opportunities in the colorectal cancer market. Stivarga ... treatment of colon or rectal cancer. Boehringer Ingelheim ... inhibitor, for the treatment of refractory CRC in ...
(Date:12/25/2014)... “Every three months the trends for evening dresses ... will be one of the hottest styles in the next ... the company releases 26 A-line sweetheart evening dresses, and announces ... , “We are trying our best to help a lady ... Along with affordable prices, we provide discounted delivery costs to ...
Breaking Medicine News(10 mins):Health News:Today a new plugin was announced from Pixel Film Studios, TransPack Volume 5 for Final Cut Pro X 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 2Health News:Pentec Health Ranks Fourteenth on The Best Places to Work in PA for 2014 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Nintedanib Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 4
... says more than 2 dozen contain dangerous ingredients not ... -- The U.S. Food and Drug Administration warned consumers ... for weight loss because they contain undeclared ingredients that ... sold in some retail stores and on the Internet ...
... developed a new generation of microscopic particles for ... nanoparticle platforms that may be readily adapted for ... , According to the investigators at Memorial ... particles are biologically safe, stable, and small enough ...
... UPTON, NY Scientists at the U.S. Department of ... structure of a third subtype of botulinum neurotoxin ... the disease botulism, and is also used in cosmetic ... a hyperactive bladder. The detailed structure, published online December ...
... you,ve been offered the perfect job. The not-so-good news ... the disabled, people with diseases like HIV, or those who ... room, undergoing a medical exam to qualify for a job ... Aviv University brings excellent news. , Medical exams are often ...
... are less sensitive to thermal (hot and cold) sensations later ... London). The study, published in the journal Pain , ... in early development may alter how children respond to painful ... 43 eleven-year-old children born at less than 26 weeks of ...
... switch ,on, in those with lupus, rheumatoid arthritis , , ... potential autoimmune disease-causing cells, but these cells stay in ... cells that attack the body cause autoimmune diseases such ... cells in healthy adults are true precursors of the ...
Cached Medicine News:Health News:FDA Warns About Weight Loss Products 2Health News:FDA Warns About Weight Loss Products 3Health News:Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting 2Health News:Researchers create smaller, brighter probe tailored for molecular imaging and tumor targeting 3Health News:Scientists reveal structure of new botulism nerve toxin subtype 2Health News:Scientists reveal structure of new botulism nerve toxin subtype 3Health News:A simple questionnaire to replace a doctor's exam 2Health News:Premature babies have altered sensory responses in later life 2
RIA kit for the quantitative determination of autoantibodies to thyroid peroxidase (TPO) in serum....
... Double Antibody Estradiol,is an 125I ... use in the quantitative,measurement of ... of precocious puberty in girls,and ... the,differential diagnosis of amenorrhea. It ...
... The assay is a direct competitive ... in human serum or plasma. A specific ... it available for antibody binding. Estradiol then ... to fluorescein isothiocyanate (FITC) and alkaline phosphatase ...
... most potent, naturally secreted estrogen and is ... [1]. In the ovary, estradiol is produced ... less potent estrogen derived from androstenedione. Estrone ... tissues. In men, small amounts of estradiol ...
Medicine Products: